Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Single Arm, Multicentre Study to Evaluate the Efficacy and Safety of a Subcutaneous Four Months Sustained-release Formulation of Triptorelin, a Gonadotrophin Releasing Hormone Analogue in Patients With Prostate Cancer

NCT00415246 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT00415246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00415246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Single Arm, Multicentre Study to Evaluate the Efficacy and Safety of a Subcutaneous Four Months Sustained-release Formulation of Triptorelin, a Gonadotrophin Releasing Hormone Analogue in Patients With Prostate Cancer
Lead sponsor
Ipsen
Phase
Phase 3
Overall status
Terminated
Start date
November 30, 2006
Completion date
October 31, 2007
Enrollment
100 (estimated)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer